Bruce Conklin, MD, introduces you to CRISPR, a disruptive technology influencing advances in treatment and cures of diseases through gene editing. Conklin walks you through how CRISPR works before diving into its evolution in his lab at Gladstone, using application examples such as treating cancer, curing Alzheimer’s, and testing drug therapies to prevent cardiac damage in COVID-19 patients. You’ll also hear about this DNA-editing technology’s bright future expanding its reach into cures for more diseases.
Melanie Ott helped shape recommendations for a unified plan to end the pandemicGladstone Experts COVID-19 Ott Lab
An expert from Gladstone Institutes helps shape the new recommendationsOffice of the Chief Operating Officer Gladstone Experts Institutional News